Malaria and children: Progress in intervention coverage - Unicef

Since around 2005 both production of and
funding for artemisinin-based combination
therapies have been rapidly scaled up
25
Malaria and children
Figure 15 Despite relatively high treatment rates, many African children receive less effective drugs
2
Comoros (2000) 63
Gambia, The (2006)
Uganda a (2006)
Ghana (2006)
Benin (2001)
Cameroon (2006)
Tanzania, United Rep. of (2004–2005)
Zambia a (2006)
Central African Republic (2006)
Congo, Dem. Rep. of the (2001)
Sierra Leone (2006)
Sudan (2000)
Equatorial Guinea (2000)
Burkina Faso (2006)
Congo (2005)
Togo (2006)
Guinea-Bissau (2006)
Guinea (2005)
Côte d’Ivoire (2006)
Madagascar (2003)
Nigeria a (2003)
Mauritania (2003–2004)
Niger (2006)
Chad (2000)
Burundi (2006)
Kenya (2003)
Senegal (2005)
Swaziland (2000)
São Tomé & Principe (2006)
Malawi (2006)
Mozambique (2003)
Namibia (2000)
Rwanda a (2005)
Djibouti (2006)
Somalia (2006)
Zimbabwe (2005–2006)
Eritrea (2002)
Ethiopia (2005)
27
26
25
24
15
14
12
10
8
5
4
3
63
62
61
60
58
58
58
57
52
52
50
49
48
48
48
46
44
36
34
34
33
33
32
30
27
Roll Back Malaria (Abuja) target for 2005
Roll Back Malaria target for 2010
Malaria
treatment
by drug type
Percentage of children
under age five with fever
receiving chloroquine
and any antimalarial
medicine, sub-Saharan
Africa, 2000–2006
Children under age
five with fever
receiving chloroquine
Children under age
five receiving any
antimalarial medicine
Note:
Some sub-Saharan
African countries have
a significant population
share living in nonmalarious
areas.
National-level estimates
may obscure higher
coverage in endemic
subnational areas
targeted by programmes
(see annex A).
a. Data on chloroquine
use not available.
Source:
UNICEF global malaria
database, based on 38
Multiple Indicator
Cluster Surveys,
Demographic and
Health Surveys and
Malaria Indicator
Surveys for 2000–2006.
Progress in the fight against malaria
0 20 40 60 80 100
pregnant women is not recommended for countries
with a large proportion of their population
living in areas with low-intensity malaria
transmission, such as Botswana, Burundi, Cape
Verde, Comoros, Eritrea, Ethiopia, Mauritania,
South Africa and Swaziland (see annex A).
These countries have therefore not included
intermittent preventive treatment for pregnant
women as part of their national malaria control
strategies.